Utilization of high molecular weight cytokeratin on prostate needle biopsies in an independent laboratory.
暂无分享,去创建一个
J. Epstein | G. Dasilva | H. Kahane | J. W. Sharp | G. B. Shuman | J. I. Epstein | James W. Sharp | Guy Dasilva
[1] J. Epstein,et al. The Utility of Basal Cell—Specific Anti‐Cytokeratin Antibody (34βE12) in the Diagnosis of Prostate Cancer: A Review of 228 Cases , 1995, The American journal of surgical pathology.
[2] D. Bostwick,et al. Atypical Basal Cell Hyperplasia of the Prostate: Immunophenotypic Profile and Proposed Classification of Basal Cell Proliferations , 1993, The American journal of surgical pathology.
[3] J. Epstein,et al. Nucleoli in low-grade prostate adenocarcinoma and adenosis. , 1993, Human pathology.
[4] J. Epstein,et al. Acidic mucin in the prostate: can it differentiate adenosis from adenocarcinoma? , 1992, Human pathology.
[5] J. Epstein,et al. Atypical Basal Cell Hyperplasia of the Prostate , 1992, The American journal of surgical pathology.
[6] G. Collina,et al. Sclerosing adenosis of the prostate. Report of three cases with electronmicroscopy and immunohistochemical study , 1992, Histopathology.
[7] D. Grignon,et al. Sclerosing Adenosis of the Prostate Gland: A Lesion Showing Myoepithelial Differentiation , 1992, The American journal of surgical pathology.
[8] M. Enjoji,et al. Sclerosing Adenosis of the Prostate Histopathologic and Immunohistochemical Analysis , 1991, The American journal of surgical pathology.
[9] N. Ordóñez,et al. Clear cell cribriform hyperplasia of the prostate. Immunohistochemical and DNA flow cytometric study. , 1991, American journal of clinical pathology.
[10] J. Lechago,et al. Cytokeratin immunohistochemistry as a diagnostic tool for distinguishing malignant from benign epithelial lesions of the prostate. , 1991, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
[11] J. Epstein,et al. A case showing sclerosing adenosis and an unusual form of basal cell hyperplasia of the prostate. , 1989, The American journal of surgical pathology.
[12] J. Epstein,et al. Use of Keratin 903 as an Adjunct in the Diagnosis of Prostate Carcinoma , 1989, The American journal of surgical pathology.
[13] F. Freiha,et al. Keratin immunoreactivity as an aid to the diagnosis of persistent adenocarcinoma in irradiated human prostates , 1989, Cancer.
[14] D. Grignon,et al. Basal cell hyperplasia, adenoid basal cell tumor, and adenoid cystic carcinoma of the prostate gland: an immunohistochemical study. , 1988, Human pathology.
[15] L. Layfield,et al. Keratin immunoreactivity in fine‐needle aspiration of the prostate: An aid in the differentiation of benign epithelium from well‐differentiated adenocarcinoma , 1988, Diagnostic cytopathology.
[16] D. Bostwick,et al. Prostatic Intra‐Epithelial Neoplasia and Early Invasion in Prostate Cancer , 1987, Cancer.
[17] R. Nagle,et al. Cytokeratin characterization of human prostatic carcinoma and its derived cell lines. , 1987, Cancer research.
[18] T. Stamey,et al. Keratin immunoreactivity in the benign and neoplastic human prostate. , 1985, Cancer research.
[19] A. Gown,et al. Monoclonal antibodies to human intermediate filament proteins. II. Distribution of filament proteins in normal human tissues. , 1984, The American journal of pathology.
[20] W. Scott,et al. ULTRASTRUCTURE OF THE HUMAN PROSTATE: NORMAL AND NEOPLASTIC. , 1964, Laboratory investigation; a journal of technical methods and pathology.
[21] E. Sproul,et al. Microscopic differential diagnosis of latent carcinoma of prostate. , 1953, A.M.A. archives of pathology.